NCT01846429 Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain Status TERMINATED Phase PHASE1
NCT01838512 Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT01832727 Phase 1b/2, Multicenter, Open-label Study of Oprozomib and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma Status TERMINATED Phase PHASE1/PHASE2
NCT01830816 Pharmacokinetics Study of Oral Ixazomib (MLN9708) in Relapsed/Refractory Multiple Myeloma and Advanced Solid Tumors Participants With Normal Renal Function or Severe Renal Impairment Status COMPLETED Phase PHASE1
NCT01829971 A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection Status TERMINATED Phase PHASE1
NCT01829412 Whole Body Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) in Multiple Myeloma Status COMPLETED Phase NA
NCT01827137 WT1 Vaccine Treatment of Patients With Multiple Myeloma After Autologous Stem Cell Transplantation Status COMPLETED Phase PHASE1/PHASE2
NCT01818752 Phase 3 Study of Carfilzomib, Melphalan, Prednisone vs Bortezomib, Melphalan, Prednisone in Newly Diagnosed Multiple Myeloma Status COMPLETED Phase PHASE3
NCT01811862 Acupuncture for Symptom Control in Hematopoietic Stem Cell Transplantation Patients Status COMPLETED Phase NA
NCT01801436 A Post-Approval Pharmacokinetic Study of Bortezomib in Participants With Multiple Myeloma Status COMPLETED Phase PHASE3
NCT01792102 Safety, Efficacy, and Pharmacodynamics of a 60-Minute Infusion of Carfilzomib for Progressive Multiple Myeloma Status UNKNOWN Phase PHASE1/PHASE2
NCT01790737 First Line Treatment Trial in Multiple Myeloma, Finnish Myeloma Group- Multiple Myeloma 02 Status COMPLETED Phase PHASE2
NCT01783522 Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib Status TERMINATED Phase PHASE2
NCT01782963 Lenalidomide/Bortezomib/Dexamethasone for Multiple Myeloma (MM) Status COMPLETED Phase PHASE2
NCT01780766 Whole Body MRI Imaging in Multiple Myeloma at 3 Tesla MRI : Added Value of Diffusion Weighted Imaging Status UNKNOWN Phase N/A
NCT01772719 Overcoming Chemotherapy Resistance In Refractory Multiple Myeloma With Simvastatin and Zoledronic Acid Status TERMINATED Phase NA
NCT01758328 Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple Myeloma Status COMPLETED Phase PHASE1